Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameYunkang Group
Stock Code02325
Company Full NameTo be extracted
IndustryHealthcare
Principal Activities我們是中國的一家醫學運營服務提供商,為醫療機構提供全套診斷檢測服務,主要包括診斷外包服務及為醫聯體提供的診斷檢測服務,亦向非醫療機構提供少量診斷檢測服務。
Listing Date2022-05-18
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國廣州市黃埔區科學城荔枝山路6號
Business Address (Hong Kong)香港銅鑼灣希慎道33號利園一期19樓1901室
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websiteyunkanghealth.com
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2980 1333
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism Mechanism A
Offer PriceHK$ 7.89 / shares
Offer Price RangeFinal offer price only, no range
Lot Size500 shares
Entry ThresholdHK$ 3,945
Par ValueTo be extracted
Offer Period2022-05-05 to 2022-05-11
Global Offering Shares138,188,000 shares
HK Public Offer Shares (Initial)13,819,000 shares (10.0%)
Public Offer Lots (Initial)27,638lots (Pool A13,819lots,Pool B13,819lots)
International Placing Shares (Initial)124,369,000 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO613,188,000 shares
Greenshoe (Over-allotment Option)Yes
Stabilizing Manager (Greenshoe)To be extracted
Cornerstone Share27.4%
Clawback TiersTo be extracted
Reallocation OptionYes
Total Global Offering SizeHK$ 1,090,303,320

Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 500 HK$ 3,945
2 lots 1,000 HK$ 7,890
3 lots 1,500 HK$ 11,835
4 lots 2,000 HK$ 15,780
5 lots 2,500 HK$ 19,725
6 lots 3,000 HK$ 23,670
7 lots 3,500 HK$ 27,615
8 lots 4,000 HK$ 31,560
9 lots 4,500 HK$ 35,505
10 lots 5,000 HK$ 39,450
12 lots 6,000 HK$ 47,340
14 lots 7,000 HK$ 55,230
16 lots 8,000 HK$ 63,120
18 lots 9,000 HK$ 71,010
20 lots 10,000 HK$ 78,900
30 lots 15,000 HK$ 118,350
40 lots 20,000 HK$ 157,800
50 lots 25,000 HK$ 197,250
60 lots 30,000 HK$ 236,700
70 lots 35,000 HK$ 276,150
80 lots 40,000 HK$ 315,600
90 lots 45,000 HK$ 355,050
100 lots 50,000 HK$ 394,500
120 lots 60,000 HK$ 473,400
140 lots 70,000 HK$ 552,300
200 lots 100,000 HK$ 789,000
400 lots 200,000 HK$ 1,578,000
600 lots 300,000 HK$ 2,367,000
800 lots 400,000 HK$ 3,156,000
1,000 lots 500,000 HK$ 3,945,000
1,200 lots 600,000 HK$ 4,734,000
Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1,400 lots 700,000 HK$ 5,523,000
2,000 lots 1,000,000 HK$ 7,890,000
4,000 lots 2,000,000 HK$ 15,780,000

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway Regular Path
Avg Daily HK Mkt Cap HK$ 411.2M
Est. Threshold HK$ 9.71B
Analysis Result HK market cap below threshold, need +2262%

Valuation & Financials

Market Cap (at Offer Price)HK$ 4,838,053,320
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss Status盈利約人民幣381.9百萬元
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted

Financial Data

Unit: '000 RMB
Income Statement
Item 201920202021
Revenue 677,8261,200,3201,696,740
Cost of sales -378,632-544,425-797,603
Gross profit 299,194655,895899,137
Other income and gains, net 6,11514,0567,869
Selling and distribution expenses -192,655-219,015-273,304
Administrative expenses -112,749-104,753-152,078
Operating profit 3,060341,462457,694
Net finance costs -11,731-17,075-6,474
Share of associates and JVs -1,961-1,559
Profit before tax -10,632322,828451,220
Income tax expense -757-52,519-78,722
Profit for the year -31,544260,172381,893
Profit attributable to owners -30,957255,334380,932
Balance Sheet
Item 201920202021
Cash and cash equivalents 63,955335,835800,695
Trade and bills receivables 260,405484,514825,301
Inventories 15,15624,55341,697
Total current assets 418,5521,387,9911,743,255
Total assets 1,269,2461,956,7312,455,413
Total current liabilities 411,973806,665870,838
Total liabilities 478,839890,3471,003,833
Total equity 790,4071,066,3841,451,580
Equity attributable to owners 775,6751,047,9081,451,704
Interest-bearing borrowings 186,248472,176290,685
Cash Flow Statement
Item 201920202021
Net cash from operating activities 4,847203,084369,459
Net cash from investing activities -322,815-191,094310,722
Net cash from financing activities -18,457260,992-215,321
Net increase in cash -336,425272,982464,860
Purchase of PP&E -27,370-45,334-222,918
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
First Day CloseHK$ 8.5
First Day OpenHK$ 7.89
First Day Change7.73%
First Day Volume31186000.0
First Day Turnover237815000.0
Use of Proceeds
1、約55.0%或418.5百萬港元,將用于未來四年擴大并深化我們醫聯體網絡,主要于華東地區、華中地區及華南地區; 2、約20.0%或152.2百萬港元將于未來三年內分配用于升級并提升我們醫學運營服務提供商的營運能力,以提高營運效率及數字化檢測服務; 3、約10.0%或76.1百萬港元將分配用于擴大我們的診斷能力及豐富我們的診斷檢測組合,于未來三年重點發展關鍵技術的能力; 4、約5.0%或38.0百萬港元將分配用于尋找潛在投資及收購機會; 5、約5.0%或38.0百萬港元將分配用于招聘及培訓人才庫,重點是管理及技術人員; 6、約5.0%或38.0百萬港元將用作我們的營運資金及一般企業用途。

Underwriting Syndicate

Joint Sponsors (2)
招银国际融资有限公司 CE AVM940 SPDB International Capital Limited CE BFZ375
Overall Coordinators (3)
招银国际融资有限公司 CE AVM940 SPDB International Capital Limited CE BFZ375 CHINA MERCHANTS SECURITIES (HK) CO., LIMITED CE AAI650
Joint Bookrunners (6)
招银国际融资有限公司 CE AVM940 SPDB International Capital Limited CE BFZ375 CHINA MERCHANTS SECURITIES (HK) CO., LIMITED CE AAI650 建银国际金融有限公司 CE AJO225 Leading Securities Company Limited CE BAL779 富途证券国际(香港)有限公司 CE AZT137
Joint Lead Managers (8)
招银国际融资有限公司 CE AVM940 SPDB International Capital Limited CE BFZ375 CHINA MERCHANTS SECURITIES (HK) CO., LIMITED CE AAI650 建银国际金融有限公司 CE AJO225 Leading Securities Company Limited CE BAL779 富途证券国际(香港)有限公司 CE AZT137 Blackwell Global Securities Limited CE BGX296 Livermore Holdings Limited CE BJN764

Cornerstone Investors

#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 Harvest International Premium Value (Secondary Market) Fund SPC 235,402,095 HKD — 21.59% — 6 months 2022-11-18
2 亚辉龙(香港)有限公司 62,772,840 HKD — 5.76% — 6 months 2022-11-18

Directors & Management

PositionChinese nameEnglish Name
Chairman張勇—
Company Secretary林穎嘉、陳濼而—
No director data available.

Major Shareholders

Major Shareholders & Holdings緊隨全球發售完成後,YK Development持有約40.79%權益,達安國際持有約34.21%權益,張勇先生及達安基因等為控股股東。
About this page

This page shows Yunkang Group (02325) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect